REQUEST A DEMO
Total
USD $0.00
Search more companies

Alven Laboratories S.R.O. (Czech Republic)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Alven Laboratories S.R.O. Profile Updated: November 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alven Laboratories S.R.O. is a company in Czech Republic, with a head office in Olomouc. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was first established on March 11, 2015. The total number of employees is currently 25 - 49 (2023). There was a net sales revenue drop of 0.54% reported in Alven Laboratories S.R.O.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 2.45%. The net profit margin of Alven Laboratories S.R.O. increased by 2.44% in 2023.

Headquarters
Holicka 1173/49
Olomouc; Olomoucky; Postal Code: 77900

Contact Details: Purchase the Alven Laboratories S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Alven Laboratories S.R.O. report to view the information.
Outstanding Shares:
Purchase the Alven Laboratories S.R.O. report to view the information.
Registered Capital:
Purchase the Alven Laboratories S.R.O. report to view the information.
Incorporation Date:
March 11, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
52%
Purchase this report to view the information.
33%
Company Performance
Financial values in the chart are available after Alven Laboratories S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-0.54%
Total operating revenue
-9.81%
Operating profit (EBIT)
151.92%
EBITDA
20.15%
Net Profit (Loss) for the Period
176.96%
Total assets
2.45%
Total equity
20.63%
Operating Profit Margin (ROS)
4.09%
Net Profit Margin
2.44%
Return on Equity (ROE)
9.66%
Debt to Equity Ratio
-7.41%
Quick Ratio
-0.05%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?